PRELUDE THERAPEUTICS INC's ticker is PRLD and the CUSIP is 74065P101. A total of 61 filers reported holding PRELUDE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 6.00 and the average weighting 0.0%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 10,909,256 | $33,709,601 | 0.72% |
| Boxer Capital, LLC | 2,495,018 | $7,709,606 | 0.41% |
| Sio Capital Management, LLC | 350,000 | $1,081,500 | 0.34% |
| Baker Brothers Advisors | 10,123,824 | $31,282,616 | 0.18% |
| EcoR1 Capital, LLC | 1,157,452 | $3,576,527 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 70,583 | $218 | 0.02% |
| Pale Fire Capital SE | 30,781 | $95,113 | 0.01% |
| Woodline Partners LP | 200,000 | $618,000 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 143,957 | $444,827 | 0.00% |
| EXCHANGE TRADED CONCEPTS, LLC | 32,907 | $101,683 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 36,949 | $114,172 | 0.00% |
| STATE OF WISCONSIN INVESTMENT BOARD | 61,600 | $190,344 | 0.00% |
| Squarepoint Ops LLC | 88,802 | $274,398 | 0.00% |
| China Universal Asset Management Co., Ltd. | 1,076 | $3 | 0.00% |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 510,279 | $1,576,762 | 0.00% |
| FMR LLC | 5,131,433 | $15,856,127 | 0.00% |
| TD ASSET MANAGEMENT INC | 160,652 | $496,415 | 0.00% |
| Renaissance Technologies | 139,374 | $431 | 0.00% |
| Citadel Advisors | 200 | $618 | 0.00% |
| Citadel Advisors | 1,200 | $3,708 | 0.00% |
External links
This page lists PRELUDE THERAPEUTICS INC's shareholders in Q3 2023. To view PRELUDE THERAPEUTICS INC's shareholder history, click here.